Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Harmony Gold Mining Co. (HMY) vs TransMedics Group Inc (TMDX) Price & Performance

Harmony Gold Mining Co.Trade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Harmony Gold Mining Co. vs TransMedics Group Inc — how do they compare? Harmony Gold Mining Co. trades at $19.93 (market cap $12.24B), while TransMedics Group Inc trades at $86.75 (market cap $3.10B). The key difference: Harmony Gold Mining Co. is far larger — about 3.9× TransMedics Group Inc's market cap, and Harmony Gold Mining Co. pays a 2.09% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

HMYTMDX
Market Cap
$12.24B$3.10B
Sector
Basic MaterialsTechnology
52-Week High
$26.04$150.42
52-Week Low
$12.61$61.99
Enterprise Value
$12.58B$3.49B
Dividend Yield
2.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Harmony Gold Mining Co.

Harmony Gold Mining (HMY) trades at $19.88, down 0.1% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong 2024 results with revenue of $61.38B and net income of $8.59B, supported by a strategic pivot to gold-copper production. Recent news highlights operational progress, including copper profit growth and diversification efforts.

HMY offers value with a P/E of 12.26 and robust profitability margins, but faces risks from gold price volatility and mixed analyst sentiment. The stock's outlook is supported by earnings growth and diversification, though investor caution is warranted due to Fed policy sensitivity and execution risks in expansion.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.

The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.

Returns comparison

Trailing returns across standard periods

About Harmony Gold Mining Co.

Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.

Read more on HMY

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX